Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,658,557
+$103,426 QoQ
Shares Held
10,468
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.87%
of 13F equity value
Holder Rank
#2,098
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Citrine Capital LLC holds $3,192,944 across 3 Drug Manufacturers - General names. JNJ ranks #1 (83.3% of the industry book) .
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,658,557 | 10,468 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,555,131 | 10,453 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,048,805 | 9,900 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,832,320 | 9,882 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,509,475 | 9,882 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,638,830 | 9,882 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,429,134 | 9,882 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||